Hemoglobin Oxygen Therapeutics LLC — Form D
Hemoglobin Oxygen Therapeutics LLC of SOUDERTON, PA, a company, filed a Form D exempt-offering notice with the SEC on 2015-04-13. The offering totals $2.5M, of which $150K was reported sold. Industry: Biotechnology.
Offering
- Filed: 2015-04-13
- Form: D
- Accession: 0001615647-15-000002
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $2.5M
- Amount sold: $150K
- Remaining: $2.4M
- Minimum investment: $50K
- Investors: 2
- Date of first sale: 2015-04-10
- Security types: equity
- Revenue range: $1 - $1,000,000
- SEC file number: 021-237862
Issuer
- Name: Hemoglobin Oxygen Therapeutics LLC
- CIK: 0001615647
- Entity type: Limited Liability Company
- Jurisdiction: DELAWARE
- Incorporated: 2014
- Address: 674 SOUDER ROAD, SOUDERTON, PA, 18964
- Phone: 267-382-0064
Officers, directors & promoters (5)
| Name | Role | Location |
|---|
| Gerald Raymond Kowalski | Director | Prague, 2N |
| Zafiris George Zafirelis | Director | Needham, MA |
| Gerald Raymond Kowalski | Executive Officer | Prague, 2N |
| Igor Borisovich Serov | Executive Officer | London, X0 |
| Zafiris George Zafirelis | Executive Officer | Needham, MA |
Other filings by this issuer (2)
More